The HER2MtGx Metagene Score as a Reliable Tool to Select HER2 Breast Cancer Patients for Neoadjuvant Targeted Therapy.

Saved in:
Bibliographic Details
Title: The HER2MtGx Metagene Score as a Reliable Tool to Select HER2 Breast Cancer Patients for Neoadjuvant Targeted Therapy.
Authors: Tiezzi, Daniel Guimarães1 (AUTHOR) dtiezzi@usp.br, Buzatto, Isabela Panzeri Carlotti1,2 (AUTHOR), da Silveira, Willian Abraham2,3 (AUTHOR), Monti, Anna Clara3,4 (AUTHOR), Buono, Fabiana de Oliveira1 (AUTHOR), Meola, Juliana1,2 (AUTHOR), Poli-Neto, Omero Benedicto1,3 (AUTHOR), Pagnotta, Stefano Maria4 (AUTHOR)
Source: International Journal of Molecular Sciences. Dec2025, Vol. 26 Issue 24, p11809. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms262411809